Literature DB >> 21158008

Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis.

M Radić1, D Martinović Kaliterna, J Radić.   

Abstract

Systemic sclerosis is an autoimmune disease characterised by vascular obliteration, excessive extracellular matrix deposition and fibrosis of the connective tissues of the skin, lungs, gastrointestinal tract, heart, and kidneys. The pathogenesis of systemic sclerosis is extremely complex; at present, no single unifying hypothesis explains all aspects. Over the last 20 years increasing evidence has accumulated to implicate infectious agents in the aetiology of systemic sclerosis. Increased antibody titres, a preponderance of specific strains in patients with systemic sclerosis, and evidence of molecular mimicry inducing autoimmune responses suggest mechanisms by which infectious agents may contribute to the development and progression of systemic sclerosis. Here we review the current state of knowledge of infectious risk factors in systemic sclerosis and the possible mechanisms by which infectious exposures might induce pathologic processes.

Entities:  

Mesh:

Year:  2010        PMID: 21158008

Source DB:  PubMed          Journal:  Neth J Med        ISSN: 0300-2977            Impact factor:   1.422


  8 in total

Review 1.  Systemic Scleroderma-Definition, Clinical Picture and Laboratory Diagnostics.

Authors:  Anna Kowalska-Kępczyńska
Journal:  J Clin Med       Date:  2022-04-20       Impact factor: 4.964

2.  Is Helicobacter pylori infection a risk factor for disease severity in systemic sclerosis?

Authors:  Mislav Radić; Dušanka Martinović Kaliterna; Damir Bonacin; Jadranka Morović Vergles; Josipa Radić; Damir Fabijanić; Vedran Kovačić
Journal:  Rheumatol Int       Date:  2012-12-06       Impact factor: 2.631

3.  Treatment of Rapidly Progressive Systemic Sclerosis: Current and Futures Perspectives.

Authors:  Fabian A Mendoza; Maryah Mansoor; Sergio A Jimenez
Journal:  Expert Opin Orphan Drugs       Date:  2015-11-23       Impact factor: 0.694

4.  The Role of the NLRP3 Inflammasome in Fibrosis.

Authors:  Carol M Artlett
Journal:  Open Rheumatol J       Date:  2012-06-15

Review 5.  Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22.

Authors:  Daniel S Smyk; Maria G Mytilinaiou; Piotr Milkiewicz; Eirini I Rigopoulou; Pietro Invernizzi; Dimitrios P Bogdanos
Journal:  Auto Immun Highlights       Date:  2011-09-07

Review 6.  Human Cytomegalovirus and Autoimmune Diseases: Where Are We?

Authors:  Francesca Gugliesi; Selina Pasquero; Gloria Griffante; Sara Scutera; Camilla Albano; Sergio Fernando Castillo Pacheco; Giuseppe Riva; Valentina Dell'Oste; Matteo Biolatti
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

7.  Type B insulin resistance syndrome with Scleroderma successfully treated with multiple immune suppressants after eradication of Helicobacter pylori infection: a case report.

Authors:  Guo-Qing Yang; Yi-Jun Li; Jing-Tao Dou; Bao-An Wang; Ju-Ming Lu; Yi-Ming Mu
Journal:  BMC Endocr Disord       Date:  2016-05-03       Impact factor: 2.763

8.  Impact of Human Cytomegalovirus and Human Herpesvirus 6 Infection on the Expression of Factors Associated with Cell Fibrosis and Apoptosis: Clues for Implication in Systemic Sclerosis Development.

Authors:  Maria-Cristina Arcangeletti; Maria D'Accolti; Clara Maccari; Irene Soffritti; Flora De Conto; Carlo Chezzi; Adriana Calderaro; Clodoveo Ferri; Elisabetta Caselli
Journal:  Int J Mol Sci       Date:  2020-09-03       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.